venlafaxine
Generic: venlafaxine
Labeler: ajanta pharma usa inc.Drug Facts
Product Profile
Brand Name
venlafaxine
Generic Name
venlafaxine
Labeler
ajanta pharma usa inc.
Dosage Form
TABLET, EXTENDED RELEASE
Routes
Active Ingredients
venlafaxine hydrochloride 37.5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
27241-221
Product ID
27241-221_a85661b9-217a-41ca-90d8-d1e29052e44d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA214691
Listing Expiration
2026-12-31
Marketing Start
2023-04-12
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
27241221
Hyphenated Format
27241-221
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
venlafaxine (source: ndc)
Generic Name
venlafaxine (source: ndc)
Application Number
ANDA214691 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 37.5 mg/1
Packaging
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-221-30)
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-221-90)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a85661b9-217a-41ca-90d8-d1e29052e44d", "openfda": {"upc": ["0327241222306", "0327241223303", "0327241224300", "0327241221309"], "unii": ["7D7RX5A8MO"], "rxcui": ["808744", "808748", "808751", "808753"], "spl_set_id": ["22d4817c-1f19-4490-8a38-d8904f0374f7"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-221-30)", "package_ndc": "27241-221-30", "marketing_start_date": "20230412"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-221-90)", "package_ndc": "27241-221-90", "marketing_start_date": "20230412"}], "brand_name": "Venlafaxine", "product_id": "27241-221_a85661b9-217a-41ca-90d8-d1e29052e44d", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "27241-221", "generic_name": "Venlafaxine", "labeler_name": "Ajanta Pharma USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Venlafaxine", "active_ingredients": [{"name": "VENLAFAXINE HYDROCHLORIDE", "strength": "37.5 mg/1"}], "application_number": "ANDA214691", "marketing_category": "ANDA", "marketing_start_date": "20230412", "listing_expiration_date": "20261231"}